Kang, Jae H.
Vyas, Chirag M.
Okereke, Olivia I.
Ogata, Soshiro
Albert, Michelle
Lee, I.-Min
D’Agostino, Denise
Buring, Julie E.
Cook, Nancy R.
Grodstein, Francine
Manson, JoAnn E.
Clinical trials referenced in this document:
Documents that mention this clinical trial
The VITamin D and OmegA-3 TriaL (VITAL): Rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease
https://doi.org/10.1016/j.cct.2011.09.009
25-Hydroxyvitamin D Testing and Supplementation in CKD: An NKF-KDOQI Controversies Report
https://doi.org/10.1053/j.ajkd.2014.05.018
Effects of Vitamin D3 Supplementation on Cardiovascular and Cancer Outcomes by eGFR in VITAL
https://doi.org/10.34067/kid.0006472022
Protocol for studying racial/ethnic disparities in depression care using joint information from participant surveys and administrative claims databases: an observational cohort study
https://doi.org/10.1136/bmjopen-2019-033173
Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial
https://doi.org/10.1136/bmj-2021-066452
Effect of vitamin D on cognitive decline: results from two ancillary studies of the VITAL randomized trial
https://doi.org/10.1038/s41598-021-02485-8
VITAL-Bone Health: Rationale and design of two ancillary studies evaluating the effects of vitamin D and/or omega-3 fatty acid supplements on incident fractures and bone health outcomes in the VITamin D and OmegA-3 TriaL (VITAL)
https://doi.org/10.1016/j.cct.2015.01.007
Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL)
https://doi.org/10.1016/j.cct.2015.12.022
Documents that mention this clinical trial
Protocol for studying racial/ethnic disparities in depression care using joint information from participant surveys and administrative claims databases: an observational cohort study (Pre-results)
https://doi.org/10.1136/bmjopen-2019-033173
Effect of vitamin D on cognitive decline: results from two ancillary studies of the VITAL randomized trial
https://doi.org/10.1038/s41598-021-02485-8
Documents that mention this clinical trial
Effect of vitamin D on cognitive decline: results from two ancillary studies of the VITAL randomized trial
https://doi.org/10.1038/s41598-021-02485-8
Documents that mention this clinical trial
The VITamin D and OmegA-3 TriaL (VITAL): Rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease
https://doi.org/10.1016/j.cct.2011.09.009
25-Hydroxyvitamin D Testing and Supplementation in CKD: An NKF-KDOQI Controversies Report
https://doi.org/10.1053/j.ajkd.2014.05.018
Effects of Vitamin D3 Supplementation on Cardiovascular and Cancer Outcomes by eGFR in VITAL
https://doi.org/10.34067/kid.0006472022
Protocol for studying racial/ethnic disparities in depression care using joint information from participant surveys and administrative claims databases: an observational cohort study
https://doi.org/10.1136/bmjopen-2019-033173
Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial
https://doi.org/10.1136/bmj-2021-066452
Effect of vitamin D on cognitive decline: results from two ancillary studies of the VITAL randomized trial
https://doi.org/10.1038/s41598-021-02485-8
VITAL-Bone Health: Rationale and design of two ancillary studies evaluating the effects of vitamin D and/or omega-3 fatty acid supplements on incident fractures and bone health outcomes in the VITamin D and OmegA-3 TriaL (VITAL)
https://doi.org/10.1016/j.cct.2015.01.007
Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL)
https://doi.org/10.1016/j.cct.2015.12.022
Article History
Received: 1 August 2021
Accepted: 1 November 2021
First Online: 1 December 2021
Competing interests
: The authors declare no competing interests.